학술논문

Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study.
Document Type
Article
Source
Hematological Oncology; Dec2023, Vol. 41 Issue 5, p877-883, 7p
Subject
CHRONIC lymphocytic leukemia
VENETOCLAX
PROGRESSION-free survival
LYMPHADENITIS
LYMPHATIC metastasis
MULTIVARIATE analysis
CHRONIC leukemia
Language
ISSN
02780232
Abstract
Copyright of Hematological Oncology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)